DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
about
Blood alpha-synuclein in agricultural pesticide handlers in central Washington StateCerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's DiseaseModeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal careThe Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α -Synuclein Levels in Parkinson's Disease: A Meta-AnalysisProteomics and systems biology: current and future applications in the nutritional sciencesBiochemical premotor biomarkers for Parkinson's diseaseEmerging candidate biomarkers for Parkinson's disease: a reviewCSF tau and tau/Aβ42 predict cognitive decline in Parkinson's diseaseCerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeTranscriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease.Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and ChallengesValue of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosisWhat is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?Expression and Transport of α-Synuclein at the Blood-Cerebrospinal Fluid Barrier and Effects of Manganese ExposureDJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE)Specific changes of serum proteins in Parkinson's disease patientsDecrease in plasma levels of α-synuclein is evident in patients with Parkinson's disease after elimination of heterophilic antibody interferencePark7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsisDiagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human seraCerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionPhosphorylated α-synuclein in Parkinson's disease.DJ-1 isoforms in whole blood as potential biomarkers of Parkinson diseasePlasma apolipoprotein A1 as a biomarker for Parkinson diseaseDifferentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Targeted discovery and validation of plasma biomarkers of Parkinson's disease.Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's DiseaseThe role of biomarkers and imaging in Parkinson's disease.Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.Salivary DJ-1 could be an indicator of Parkinson's disease progressionBlood-based biomarkers for Parkinson's diseaseα-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS methodBrain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson's disease.Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity
P2860
Q23922069-293515DA-53E0-461F-BEA1-5DCD5F610AF0Q26744782-CB0B0995-7AC6-4094-9F1D-DCD5F0F4D2D6Q26772285-0F3589D1-9145-40D7-AEF5-8C53FA237FC6Q26785974-64688803-6160-4C27-9805-38962588B432Q26829598-DD9A5998-1548-4173-9800-9CE3D13B2536Q27008467-3A4E3771-FAEA-4B28-8C61-DBB3144FD0EBQ27015018-8708D911-532E-40A6-884F-7AA14084683AQ27304608-DFCB2F77-351F-4DA5-81BD-B2D3B8658D1CQ27311994-99027440-6E21-4717-A723-F36BE31AB6CFQ27322563-B6BB852E-FCFC-47AC-B1D8-2DD1F08E2B63Q27333275-67B83482-C860-44A2-8C15-F983C5E669E2Q27333599-032E476F-9324-4AB3-A575-1CE76928A1EDQ27686837-4A9F14DB-FCA6-422A-BA53-05CC7A2975F1Q28072061-B8B98E13-1E16-43B5-9484-185CEC899201Q28082380-384B7C73-5991-4BDA-A7A0-7984E8F213CCQ28083203-E68D42EE-812F-4B28-A17D-06E04D706744Q28395564-05AC486B-371F-4BBC-B55F-C9F20343EF5AQ28534455-2C3C8BCD-413A-4D68-B21E-8E7D4B9E56C4Q28538260-7BC2304C-D948-4EC3-B25C-2102F6A8343BQ28545821-82199770-6B6B-454E-B2F4-E44477936034Q28592872-B0D4815D-A8AD-4519-B0F9-6B93D1EFABA1Q28731824-6D716804-6C4A-43B2-9876-59D942B53803Q30405991-C49AFD9B-6AE6-433C-B9C2-C682B39BDFF8Q30496676-FBBF7F9C-3817-4B62-8003-AF5C2881A005Q30497763-4565C391-B2F0-429B-9EB2-8E3FFC2366CEQ30501271-0D8E926F-DF83-42D6-9259-747F74D6A719Q30510167-5617717F-3016-4A45-A285-B6629394D278Q30529658-77190E9C-A680-4049-8107-2798B30CAA52Q30544798-CA187F5F-DA0C-41FD-9959-3513069E762AQ30588544-A5138480-9799-43CA-8260-202E062AC811Q30597182-4B7BDCE4-FE7D-4130-ACE5-0DEBD35C91E7Q30659251-CCB5DF53-0D3C-4BA4-9400-9074EC599B32Q31041660-F9DDF914-1FFD-42F8-9F6C-B2E8C4D81A2BQ33666297-5153888C-319B-4946-8531-F56F292D6C5CQ33719372-3DBE48B5-6A56-44E7-B2D5-9DA955A304CBQ33804255-BC831A22-4294-4A95-A1A5-240988EBCC0AQ33889446-073074A9-2530-4BC0-8941-9CBB45A0061AQ33933189-D45F4096-8D8A-41D7-9699-FFAC0AF82808Q33997655-68C3EBF9-888F-4277-BFA5-CF889D1462C6Q34211654-F6CDE468-3985-47FF-95DC-3BF5096313A5
P2860
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease
@ast
DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease
@en
type
label
DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease
@ast
DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease
@en
prefLabel
DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease
@ast
DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease
@en
P2093
P2860
P50
P921
P356
P1433
P1476
DJ-1 and alpha-synuclein in hu ...... markers of Parkinson's disease
@en
P2093
Aneeka M Hancock
Catherine Pan
Douglas Galasko
Elaine R Peskind
Geoffrey Baird
Hyejin Hwang
James B Leverenz
Joseph F Quinn
Joshua Bradner
Kathryn A Chung
P2860
P304
P356
10.1093/BRAIN/AWQ008
P407
P577
2010-02-15T00:00:00Z